jenny, Author at Society for Pediatric Pain Medicine

Question of the Month – February 2023

A 17-year-old male patient presents to the OR for emergent right ankle open reduction internal fixation for fracture of the right ankle obtained when playing basketball. The patient has a past medical history of well-controlled asthma, eczema, and seasonal allergies. He also has a history of opioid use disorder that was diagnosed after he was noted to have aberrant behavior in his classroom and his mother found her post-operative oxycodone pill bottle was empty. Six months ago, he was placed on medication for opioid use disorder (MOUD) that included buprenorphine 4 mg sublingual twice per day. Which of the following is NOT a correct statement regarding buprenorphine?

A. Buprenorphine should not be routinely discontinued or tapered in the perioperative setting.

B. Buprenorphine is extensively metabolized by the liver via CYP3A4 with first pass metabolism and has low oral bioavailability.

C. In order for a clinician to prescribe buprenorphine they need to first obtain a DATA-waiver (X-waiver).

D. Buprenorphine is 25-40 times more potent than morphine.

Correct! Wrong!

Question of the Month - February 2023

SPPM is NOW on YouTube!

SPPM has launched an official YouTube channel where our latest videos including our popular Visual Pearl series are available for easy access and education.

Subscribe to our channel here: www.youtube.com/@PedsPainMed

Question of the Month – January 2023

A 17-year-old girl presents to your chronic pain clinic with neuropathic pain of her right leg secondary to osteosarcoma of the right femur. She has severe persistent neuropathic pain despite treatment with pregabalin, duloxetine, physiotherapy, and psychological treatments. The teen and her parents are interested in exploring cannabinoids for treatment of her pain and want to discuss this further with you. Which one of the following statements is incorrect?

A. Recent systematic review on cannabinoids as medical treatment in children and adolescents showed insufficient evidence for its use in chronic pain conditions such as spasticity and neuropathic pain.

B. There is evidence from recreational cannabis users suggesting the chronic use of cannabis may have adverse effects on the developing brain.

C. Nabilone is an orally administered synthetic cannabinoid and analogue of cannabidiol (CBD).

D. In a small cohort study on the use of nabilone in children with severe non-cancer pain, the most common reported side effects were sedation and cognitive slowing.

Correct! Wrong!

Question of the Month - January 2023

Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity is Doing the Same Thing Over and Over and Expecting Different Results

New Study on Quadratus Lumborum Catheters for Perioperative Analgesia

A case series has been published looking at a preliminary group of pediatric patients who received quadratus lumborum catheters as proxy for epidurals. All catheters functioned successfully and were in place for a median of 79.3 h. Other than early inadvertent removal of two catheters, no adverse effects were noted.

Read the paper here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635806/pdf/jocmr-14-425.pdf

Member Menu

Question of the Month – February 2023

SPPM is NOW on YouTube!

Question of the Month – January 2023

Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity is Doing the Same Thing Over and Over and Expecting Different Results

New Study on Quadratus Lumborum Catheters for Perioperative Analgesia

Upcoming Meeting Information